The Fanconi Anemia pathway, named after a cancer-predisposition syndrome, is essential for the repair of DNA-interstrand crosslinks (ICLs). The pathway consists of 22 FA complementation group proteins ...
The genetic basis of Fanconi anemia (FA) is mysterious and complex, as none of the five genes previously associated with the disorder have homology to genes encoding proteins of known function.
Fanconi anaemia is an inherited genetic condition of bone marrow that causes a predisposition to cancer. Researchers at King Abdullah International Medical Research Center (KAIMRC) have gained ...
"These findings could eventually lead to new strategies incorporating Fanconi anemia pathway inhibition with other drugs to combat the emergence of therapy-resistant cancer cells, which represents ...
In the area of growth control, our recent work is focused on the mTOR pathway that controls multiple aspects of cell growth and homeostasis. Our work on genomic integrity ranges from the Fanconi ...
RP-L102, Rocket's gene therapy in treatment of Fanconi Anemia, will likely have a BLA filing in Q4, 2024. In Pioneer, I pointed to the potential baked into its late-stage pipeline, while warning ...
The third and final risk to consider would be in terms of the regulatory filings and reviews of gene therapy RP-L102 for the treatment of patients with Fanconi Anemia [FA]. The risk here is that ...
Niece of Jack (Lisa) Nash & Stephen Nash. Service & Interment Wheatland, WY. Contributions: Fanconi Anemia Research Fund. Click here to Send Flowers to the family of Teri. Published in ...